Multimers for reducing the interference of drugs that bind cd47 in serological assays
AssigneeALX Oncology Inc.
InventorsJaume PONS, Bang Janet SIM, Amy Shaw-Ru CHEN, Emma Ruth SANGALANG
Life of this patent
Estimating the term…
Abstract
Provided are methods of reducing and/or preventing interference by a drug comprising (i) an antibody Fc region and (ii) a moiety that binds to human CD47 in serological assays.
Claims35
A method of reducing drug interference in a serological assay using reagent red blood cells (RBC) or reagent platelets, said method comprising:
- (a) adding a CD47 multimer that binds to the drug and blocks the drug from binding the reagent RBC or the reagent platelets to a plasma sample from a subject who has received treatment with the drug;
- and
- (b) performing the serological assay of the plasma sample after step (a), using the reagent RBC or the reagent platelets,
- wherein the drug comprises (i) a human antibody Fc region or variant thereof and (ii) a moiety that binds to human CD47, and
- wherein the CD47 multimer comprises at least two CD47 polypeptide monomers.
2-65. (canceled)
A method of reducing drug interference in a serological assay using reagent red blood cells (RBC) or reagent platelets, said method comprising:
- (a) adding an anti-SIRP multimer that binds to the drug and blocks the drug from binding the reagent RBC or the reagent platelets to a plasma sample from a subject who has received treatment with the drug;
- and
- (b) performing the serological assay of the plasma sample after step (a), using the reagent RBC or the reagent platelets,
- wherein the drug comprises (i) a human antibody Fc region or variant thereof and (ii) a moiety that binds to human CD47, and
- wherein the anti-SIRP multimer comprises one or more anti-SIRP antibodies or drug-binding fragments thereof.
(canceled)
86-87. (canceled)
89-90. (canceled)
92-93. (canceled)
95-96. (canceled)
(canceled)
100-170. (canceled)
An anti-SIRP multimer comprising one or more anti-SIRP antibodies or drug-binding fragments thereof.
172-191. (canceled)
Dependencies are inferred from the claim text.